Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors

RD Seban, L Mezquita, A Berenbaum, L Dercle… - European journal of …, 2020 - Springer
… al, who showed that FDG PET predicted efficacy and survival … predictive value of baseline
FDG PET remains unclear in … metabolic tumor burden identified in pretreatment FDG PET scans…

Prognostic value of metabolic tumor burden from 18F-FDG PET in surgical patients with non–small-cell lung cancer

H Zhang, K Wroblewski, S Liao, R Kampalath… - Academic radiology, 2013 - Elsevier
… Baseline whole-body metabolic tumor burden as measured with MTV WB and TLG WB on
FDG PET is a prognostic measure independent of clinical stage and other prognostic factors …

Tumor burden assessment with positron emission tomography with [18-F] 2-fluoro 2-deoxyglucose (FDG PET) modeled in metastatic renal cell cancer

T Akhurst, V Ng, SM Larson, JA O'Donoghue… - Clinical Positron …, 2000 - Elsevier
tumor, it is a reasonable step to assume that FDG-PET TLG could be used to evaluate the
tumor burden … We propose the use of FDG PET for measurements of tumor burden in renal cell …

Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer

S Liao, BC Penney, K Wroblewski, H Zhang… - European journal of …, 2012 - Springer
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with …
of the tumor; no metabolic tumor burden or volumetric information has been used from PET/CT …

[HTML][HTML] Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer …

A Haghighat Jahromi, DA Barkauskas, M Zabel… - EJNMMI research, 2020 - Springer
… 2-[ 18 F]FDG PET imaging has been suggested as a diagnostic tool to estimate tumor … 18
F]FDG PET–CT versus the biopsy [4]. In our study, the biopsy was taken ≤ 6 months before the …

[HTML][HTML] Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer

G Sun, C Cheng, X Li, T Wang, J Yang, D Li - Cancer Imaging, 2019 - Springer
… This study aims to investigate the prognostic value of whole body (WB) metabolic tumor
burden (MTB WB ) on postsurgical 18 F-FDG PET/CT to patients with gastric cancer. …

Metabolic tumor burden quantified on [18F]FDG PET/CT improves TNM staging of lung cancer patients

P Lapa, B Oliveiros, M Marques, J Isidoro… - European Journal of …, 2017 - Springer
Metabolic tumor burden quantified on [18F]FDG PET/CT improves TNM staging of lung
cancer patients | European Journal of Nuclear Medicine and Molecular Imaging …

… between overall survival of patients with non–small cell lung cancer and whole-body metabolic tumor burden seen on postsurgical fluorodeoxyglucose PET images

C Zhang, C Liao, BC Penney, DE Appelbaum… - Radiology, 2015 - pubs.rsna.org
… Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III
non… Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with …

[HTML][HTML] Tumor burden measured by 18F-FDG PET/CT in predicting efficacy and adverse effects of chimeric antigen receptor T-cell therapy in non-Hodgkin lymphoma

R Hong, E Tan Su Yin, L Wang, X Zhao, L Zhou… - Frontiers in …, 2021 - frontiersin.org
tumor burdens were found to have significantly increased CRS incidence and cytokine levels.
In conclusion, the PET/… assessment system of tumor burden using 18F-FDG PET/CT, which …

Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer: 18F-FDG PET …

S Morbelli, A Alama, G Ferrarazzo, S Coco… - Journal of nuclear …, 2017 - Soc Nuclear Med
… between cfDNA and 18 F-FDG PET in patients with advanced NSCLC before … tumor DNA
and 18 F-FDG PET–assessed tumor burden. However, only the whole-body metabolic tumor